SCHEMBL3209872

SCHEMBL3209872

Cc1cccnc1N1CCN(S(=O)(=O)c2ccc3oc4ccccc4c3c2)CC1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 7/20 0.64
SMN1; SMN2 Q16637 3/20 0.61
F13A1 P00488 1/20 0.52
TGM2 P21980 1/20 0.52
TGM1 P22735 1/20 0.52
TGM3 Q08188 1/20 0.52
TSHR P16473 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
HTT P42858 2/20 0.49
KDM4E B2RXH2 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C19 P33261 1/20 0.49
HPGD P15428 1/20 0.49
GBA1 P04062 2/20 0.48
RAB9A P51151 1/20 0.48
USP2 O75604 1/20 0.48
LMNA P02545 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
RXFP1 Q9HBX9 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3212628 0.94 HSD11B1 (0.64) HSD11B1SMN1; SMN2F13A1TGM2TGM1
SCHEMBL3212862 0.85 HSD11B1 (0.68) HSD11B1SMN1; SMN2
SCHEMBL3221605 0.81 HSD11B1 (0.64) HSD11B1SMN1; SMN2F13A1TGM2TGM1
SCHEMBL3223586 0.80 HSD11B1 (0.72) HSD11B1SMN1; SMN2F13A1TGM2TGM1
SCHEMBL3201987 0.79 HSD11B1 (0.64) HSD11B1SMN1; SMN2F13A1TGM2TGM1
SCHEMBL3226054 0.79 HSD11B1 (0.73) HSD11B1SMN1; SMN2F13A1TGM2TGM1
SCHEMBL3211933 0.79 HSD11B1 (0.68) HSD11B1TSHR
SCHEMBL3223804 0.78 HSD11B1 (0.79) HSD11B1SMN1; SMN2F13A1TGM2TGM1
SCHEMBL3217991 0.76 HSD11B1 (0.81) HSD11B1F13A1TGM2TGM1TGM3
SCHEMBL6988647 0.74 SMN1; SMN2 (0.78) SMN1; SMN2TSHRL3MBTL1HTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029648-A1 11-Beta HSD1 Inhibitors XIANG JASON SHAOYUN 2010-02-04 US disclosed
US-7632838-B2 11-beta HSD1 inhibitors WYETH (US) 2009-12-15 US disclosed
US-20070219198-A1 11-Beta HSD 1 inhibitors WYETH (US) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029648-A1 11-Beta HSD1 Inhibitors HSD11B1, HSD3B1, HSD11B2 HSD11B1 1/4885SMN1; SMN2 3575/4885F13A1 3898/4885
US-20070219198-A1 11-Beta HSD 1 inhibitors HSD11B1, HSD11B2, HSD3B1 HSD11B1 1/4885SMN1; SMN2 3686/4885F13A1 3856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.